Latest Articles
Bram Public Policy Lab at Colby College collaborates with Waterville to study effectiveness of paramedicine program - newscentermaine.com
Bram Public Policy Lab at Colby College collaborates with Waterville to study effectiveness of paramedicine program newscentermaine.com
Published: April 4, 2026, 10:42 p.m.
A family medicine expert shares what travelers need to know to stay safe from serious illnesses - newscentermaine.com
A family medicine expert shares what travelers need to know to stay safe from serious illnesses newscentermaine.com
Published: April 2, 2026, 2:40 p.m.
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Doses First Patient in Phase III Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: March 30, 2026, 1:56 p.m.
Precision medicine may be on the way for patients with endometriosis - Medical Xpress
Precision medicine may be on the way for patients with endometriosis Medical Xpress
Published: March 29, 2026, 3 p.m.
Hope Medicine Initiates Phase III Trial Of HMI 115 For Endometriosis - BioPharma APAC
Hope Medicine Initiates Phase III Trial Of HMI 115 For Endometriosis BioPharma APAC
Published: March 25, 2026, 6:53 p.m.
Insilico Medicine and Aska enter gynecological collaboration - BioWorld MedTech
Insilico Medicine and Aska enter gynecological collaboration BioWorld MedTech
Published: March 25, 2026, 1 p.m.
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis - Femtech Insider
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis Femtech Insider
Published: March 25, 2026, 12:34 p.m.
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health - BioSpectrum Asia
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health BioSpectrum Asia
Published: March 25, 2026, 6:37 a.m.
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - digitalmore.co
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis digitalmore.co
Published: March 25, 2026, 12:42 a.m.
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis - The Manila Times
Hope Medicine Announces First Patient Dosed in the Phase III Clinical Trial for Endometriosis The Manila Times
Published: March 25, 2026, 12:24 a.m.
Link copied to clipboard!